These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 15753622
1. Regulation of apoptosis in external auditory canal cholesteatoma by hepatocyte growth factor/scatter factor. Naim R, Shen T, Riedel F, Bran G, Sadick H, Hormann K. ORL J Otorhinolaryngol Relat Spec; 2005; 67(1):45-50. PubMed ID: 15753622 [Abstract] [Full Text] [Related]
2. Co-expression of different angiogenic factors in external auditory canal cholesteatoma. Naim R, Riedel F, Gotte K, Bran G, Sadick H, Gossler U, Hormann K. Acta Otolaryngol; 2004 Jun; 124(5):563-8. PubMed ID: 15267172 [Abstract] [Full Text] [Related]
4. Hepatocyte growth factor/scatter factor induces VEGF in human external auditory canal cholesteatoma cell culture. Naim R, Sadick H, Bayerl C, Riedel F, Schafer C, Bran G, Hormann K. Int J Mol Med; 2005 Jan 15; 15(1):67-71. PubMed ID: 15583829 [Abstract] [Full Text] [Related]
5. The role of S100A1 in external auditory canal cholesteatoma. Naim R, Hormann K. Oncol Rep; 2006 Oct 15; 16(4):671-5. PubMed ID: 16969478 [Abstract] [Full Text] [Related]
6. Influence of hepatocyte growth factor/scatter factor (HGF/SF) on fibroblast growth factor-2 (FGF-2) levels in external auditory canal cholesteatoma (EACC) cell culture. Naim R, Chang RC, Sadick H, Hormann K. In Vivo; 2005 Oct 15; 19(3):599-603. PubMed ID: 15875782 [Abstract] [Full Text] [Related]
7. Expression of vascular endothelial growth factor in external auditory canal cholesteatoma. Naim R, Riedel F, Hormann K. Int J Mol Med; 2003 May 15; 11(5):555-8. PubMed ID: 12684689 [Abstract] [Full Text] [Related]
8. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M. Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476 [Abstract] [Full Text] [Related]
9. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Hendrix MJ, Seftor EA, Seftor RE, Kirschmann DA, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R. Am J Pathol; 1998 Apr 15; 152(4):855-63. PubMed ID: 9546344 [Abstract] [Full Text] [Related]
10. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Kim CH, Moon SK, Bae JH, Lee JH, Han JH, Kim K, Choi EC. Acta Otolaryngol; 2006 Jan 15; 126(1):88-94. PubMed ID: 16308260 [Abstract] [Full Text] [Related]
11. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398 [Abstract] [Full Text] [Related]
12. External auditory canal cholesteatoma: analysis of the integrity of the tissue structure. Naim R, Sadick H, Schafer C, Hormann K. Int J Mol Med; 2004 Oct 15; 14(4):601-4. PubMed ID: 15375588 [Abstract] [Full Text] [Related]
13. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Briggs MC, Grierson I, Hiscott P, Hunt JA. Invest Ophthalmol Vis Sci; 2000 Sep 15; 41(10):3085-94. PubMed ID: 10967068 [Abstract] [Full Text] [Related]
14. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J. FASEB J; 2002 Jan 15; 16(1):108-10. PubMed ID: 11729097 [Abstract] [Full Text] [Related]
15. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas. Choi JH, Lee SH, Lee HM, Lee SH, Jung HH, Choi J, Lim HW, Lee SW, Kang SM. Acta Otolaryngol; 2006 Jul 15; 126(7):724-9. PubMed ID: 16803712 [Abstract] [Full Text] [Related]
16. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Recio JA, Merlino G. Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907 [Abstract] [Full Text] [Related]
17. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue. Lindemann K, Resau J, Nährig J, Kort E, Leeser B, Annecke K, Welk A, Schäfer J, Vande Woude GF, Lengyel E, Harbeck N. Histopathology; 2007 Jul 01; 51(1):54-62. PubMed ID: 17593080 [Abstract] [Full Text] [Related]
18. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse. Yang XM, Park M. Lab Invest; 1995 Oct 01; 73(4):483-91. PubMed ID: 7474919 [Abstract] [Full Text] [Related]
19. Inhibition of apoptosis-inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons. Ishihara N, Takagi N, Niimura M, Takagi K, Nakano M, Tanonaka K, Funakoshi H, Matsumoto K, Nakamura T, Takeo S. J Neurochem; 2005 Dec 01; 95(5):1277-86. PubMed ID: 16135073 [Abstract] [Full Text] [Related]
20. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Lal B, Xia S, Abounader R, Laterra J. Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633 [Abstract] [Full Text] [Related] Page: [Next] [New Search]